Rate and rhythm control in atrial fibrillation. Pharmacological approaches

被引：0

作者：

Weipert, K. F. ^{[1
]}

Erkapic, D. ^{[1
]}

Schmitt, J. ^{[1
]}

机构：

[1] Univ Klin Giessen, Med Klin Kardiol 1, D-35392 Giessen, Germany

来源：

HERZ | 2015年 / 40卷 / 01期

关键词：

Atrial fibrillation; Pharmacological therapy; Antiarrhythmic agents; Rate control; Rhythm control; LONG-QT-SYNDROME; QUALITY-OF-LIFE; INTRAVENOUS AMIODARONE; EUROPEAN HEART; SINUS RHYTHM; CARDIOVERSION; CONVERSION; DRONEDARONE; WARFARIN; EFFICACY;

D O I：

10.1007/s00059-014-4201-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation is the most common form of cardiac arrhythmia, occurring in 1-2 % of the population and due to an increased life expectancy the prevalence will increase further. Pharmacological treatment of atrial fibrillation is an important component of basic initial therapeutic options for patients with atrial fibrillation. Independent of an individually adjusted prevention of thromboembolism, rate and rhythm management can also be carried out. While rate control mainly applies to all patients, rhythm control is only indicated in patients who remain clinically symptomatic despite sufficient rate control. Profound knowledge about antiarrhythmic drugs including specific interactions is necessary due to the variable individual effects and sometimes severe side effects.

引用

页码：16 / 24

页数：9

共 61 条

[11] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[12] Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone - A randomized, placebo-controlled study [J].

Cotter, G ;

Blatt, A ;

Kaluski, E ;

Metzkor-Cotter, E ;

Koren, M ;

Litinski, I ;

Simantov, R ;

Moshkovitz, Y ;

Zaidenstein, R ;

Peleg, E ;

Vered, Z ;

Golik, A .

EUROPEAN HEART JOURNAL, 1999, 20 (24) :1833-1842

[13] The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy [J].

Dorian, P ;

Jung, W ;

Newman, D ;

Paquette, M ;

Wood, K ;

Ayers, GM ;

Camm, J ;

Akhtar, M ;

Luderitz, B .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1303-1309

[14] The mechanism of atrial antiarrhythmic action of RSD1235 [J].

Fedida, D ;

Orth, PMR ;

Chen, JYC ;

Lin, SP ;

Plouvier, B ;

Jung, G ;

Ezrin, AM ;

Beatch, GN .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (11) :1227-1238

[15] Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation [J].

Flaker, Greg ;

Lopes, Renato D. ;

Al-Khatib, Sana M. ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Tinga, Brian ;

Zhu, Jun ;

Mohan, Puneet ;

Garcia, David ;

Bartunek, Jozef ;

Vinereanu, Dragos ;

Husted, Steen ;

Harjola, Veli Pekka ;

Rosenqvist, Marten ;

Alexander, John H. ;

Granger, Christopher B. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (11) :1082-1087

[16] Safety of Dronedarone in Routine Clinical Care [J].

Friberg, Leif .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) :2376-2384

[17] Electrophysiological effects of ibutilide in patients with accessory pathways [J].

Glatter, KA ;

Dorostkar, PC ;

Yang, YF ;

Lee, RJ ;

Van Hare, GF ;

Keung, E ;

Modin, G ;

Scheinman, MM .

CIRCULATION, 2001, 104 (16) :1933-1939

[18] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].

Go, AS ;

Hylek, EM ;

Phillips, KA ;

Chang, YC ;

Henault, LE ;

Selby, JV ;

Singer, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375

[19] Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].

Granger, Christopher B. ;

Alexander, John H. ;

McMurray, John J. V. ;

Lopes, Renato D. ;

Hylek, Elaine M. ;

Hanna, Michael ;

Al-Khalidi, Hussein R. ;

Ansell, Jack ;

Atar, Dan ;

Avezum, Alvaro ;

Cecilia Bahit, M. ;

Diaz, Rafael ;

Easton, J. Donald ;

Ezekowitz, Justin A. ;

Flaker, Greg ;

Garcia, David ;

Geraldes, Margarida ;

Gersh, Bernard J. ;

Golitsyn, Sergey ;

Goto, Shinya ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Horowitz, John ;

Mohan, Puneet ;

Jansky, Petr ;

Lewis, Basil S. ;

Luis Lopez-Sendon, Jose ;

Pais, Prem ;

Parkhomenko, Alexander ;

Verheugt, Freek W. A. ;

Zhu, Jun ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992

[20] QUALITY-OF-LIFE ASSESSMENT IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION OR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA [J].

HAMER, ME ;

BLUMENTHAL, JA ;

MCCARTHY, EA ;

PHILLIPS, BG ;

PRITCHETT, ELC .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (08) :826-829

← 1 2 3 4 5 6 7 →